Citation: Bb. Gollapudi et G. Krishna, Practical aspects of mutagenicity testing strategy: an industrial perspective, MUT RES-F M, 455(1-2), 2000, pp. 21-28
Citation: Gd. Charles et al., Activity of benzo[a]pyrene and its hydroxylated metabolites in an estrogenreceptor-alpha reporter gene assay, TOXICOL SCI, 55(2), 2000, pp. 320-326
Citation: Da. Delker et al., Evaluation of cytotoxicity, cell proliferation, and genotoxicity induced by p-cresidine in hetero- and nullizygous transgenic p53 mice, TOXICOL SCI, 55(2), 2000, pp. 361-369
Authors:
Charles, GD
Gennings, C
Clemons, J
Zacharewski, TR
Gollapudi, BB
Carney, EW
Citation: Gd. Charles et al., Optimization of an estrogen receptor-alpha transcriptional activation assay for testing a diverse spectrum of chemicals, J APPL TOX, 20(6), 2000, pp. 449-454
Authors:
Gollapudi, BB
Charles, JM
Linscombe, VA
Day, SJ
Bus, JS
Citation: Bb. Gollapudi et al., Evaluation of the genotoxicity of 2,4-dichlorophenoxyacetic acid and its derivatives in mammalian cell cultures, MUT RES-GTE, 444(1), 1999, pp. 217-225
Citation: Da. Delker et al., V-Ha-ras gene expression in liver and kidney of transgenic Tg.AC mice following chemically induced tissue injury, TOXICOL SCI, 50(1), 1999, pp. 90-97
Citation: Bb. Gollapudi et al., Mode of action considerations in the use of transgenic animals for mutagenicity and carcinogenicity evaluations, TOX LETT, 103, 1998, pp. 479-484